Profil
Kristin Stephens is currently the Chief Development Officer at Syros Pharmaceuticals, Inc. She previously worked as the Vice President-Global Clinical Operations at Millennium Pharmaceuticals, Inc. and as a Vice President at Takeda Pharmaceuticals U.S.A., Inc. She completed her undergraduate degree at Hobart & William Smith Colleges.
Postes actifs de Kristin Stephens
| Sociétés | Poste | Début |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2018 |
Anciens postes connus de Kristin Stephens
| Sociétés | Poste | Fin |
|---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | - |
Formation de Kristin Stephens
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Hobart & William Smith Colleges
Hobart & William Smith Colleges Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
















